$ Value
$57K
Shares
300
Price
$191
Filed
Mar 16
Insider
Name
Rabinowitz Matthew
Title
EXECUTIVE CHAIRMAN
CIK
0001646382
Roles
Transaction Details
Transaction Date
2026-03-16
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,360,372
Footnotes
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.09 to $187.08 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.09 to $188.08 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $189.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.10 to $190.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.10 to $191.04 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.10 to $192.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.10 to $193.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.10 to $194.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.10 to $195.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.07 to $188.06 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.07 to $189.06 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.07 to $190.06 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.07 to $190.94 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.08 to $191.37 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.61 to $190.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.6650 to $190.7800 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.40 to $192.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.63 to $194.47 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.76 to $195.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.7600 to $196.7550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.76 to $197.68 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.98 to $198.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The option shares are fully exercisable.
Filing Info
Rabinowitz Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-06 | NTRA | M | $559K |
| 2026-04-06 | NTRA | F | $5.7M |
| 2026-04-06 | NTRA | M | $0 |
| 2026-03-31 | NTRA | M | $400K |
| 2026-03-31 | NTRA | M | $0 |
| 2026-03-16 | NTRA | M | $480K |
| 2026-03-16 | NTRA | ▼ | $19K |
| 2026-03-16 | NTRA | ▼ | $57K |
| 2026-03-16 | NTRA | ▼ | $173K |
| 2026-03-16 | NTRA | ▼ | $447K |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.2M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $4.5M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |